Drug Database
Back to search

Ireland· IE-PA-PA23148/003/001

Timolol 0.25% w/v Eye Drops, Solution

A timolol product containing timolol, registered in Ireland by Brown & Burk IR Limited. The same ATC class is registered in 8 of our 19 countries.

ATC C07AA06

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedTimolol 0.25% w/v Eye Drops, SolutionATCC07AA06REGISTER NO.IE-PA-PA23148/003/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about timololAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Timolol is registered in 8 of 19 countries.

Countries holding a registration under ATC C07AA06 (timolol), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 4 of them publish a price we can compare per daily dose
Search timolol products by name

Timolol · ATC C07AA06

8 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Japan
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Timolol
Manufacturer
Brown & Burk IR Limited
Country
Ireland (IE)
ATC code
C07AA06
ATC class
Timolol
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23148/003/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

310 interactions on record for timolol.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check timolol against other medicinesHow interaction checks work

Timolol · interactions on record

310 records

  • 31 severe
  • 189 moderate
  • 23 minor
  • 67 info

Most severe, free to view

  • DolasetronA04AA04severe
  • EpinephrineB02BC09severe
  • EpinephrineC01CA24severe
  • OrciprenalinC01CA29severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Timolol in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All timolol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Timoftal, Timolol Micro Labs
  • Belgium · Geltim, Timabak
  • Bulgaria · Гелтим, Кузимолол
  • Cyprus · Lithimole
  • Czechia · Oftan, Timo-Comod
  • Germany · Dispatim, Gelisia
  • Denmark · Eyopto, Optimol
  • Estonia · Timosan
  • Spain · Cusimolol, Gelisia
  • Finland · Oftan Timolol, Timosan
  • France · Geltim Lp, Genoptol
  • United Kingdom (Northern Ireland) · Eysano, Timolol Blumont Pharma
  • Greece · Geltim, Lithimole
  • Croatia · Timalen
  • Hungary · Cusimolol
  • Iceland · Timosan Depot
  • Italy · Blocadren, Cusimolol
  • Lithuania · Oftan, Timosan
  • Luxembourg · Dispatim, Geltim
  • Latvia · Oftan Timolol, Timosan
  • Malta · Lithimole
  • Netherlands · Gelisia, Timo-Comod
  • Norway · Oftan, Timosan
  • Poland · Cusimolol, Timo-Comod 0,5 %
  • Portugal · Dibetop, Timabak
  • Romania · Gelisia, Geltim
  • Sweden · Optimol, Timosan
  • Slovenia · Timalen, Timoptic -Xe
  • Slovakia · Unitimolol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e974ffba-90be-4a0b-a907-eb8f72958320
GET /v1/drugs/e974ffba-90be-4a0b-a907-eb8f72958320?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, solution",
  "routes": [
    "Intraocular use"
  ],
  "source": "hpra",
  "atc_all": [
    "C07AA",
    "C07AA06"
  ],
  "strength": null,
  "pa_number": "PA23148/003/001",
  "substances": [
    "Timolol"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "15/02/2013",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about timolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console